SAN FRANCISCO – The mood heading into the start of the 33rd annual J.P. Morgan Healthcare Conference in San Francisco that opens today will be decidedly upbeat. In fact, it will be hard for biotech executives to stop smiling with the industry coming off a record year in terms of raising capital, performance on the capital markets and partnering and mergers and acquisitions. Equally gratifying is that all signs are pointing toward another repeat performance this year. Read More
